This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Advinus Therapeutics Private Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Minakshi Naykodi: Innovator in Pharmaceutical Development
Introduction
Minakshi Naykodi, an accomplished inventor based in Hinjewadi, India, has made significant contributions to the field of pharmaceuticals. With one patent to her name, she is recognized for her innovative work that addresses critical health issues through sophisticated chemical compounds.
Latest Patents
Minakshi holds a patent for "Fused tricyclic compounds as adenosine receptor antagonist." This invention involves unique fused tricyclic compounds, their tautomers, polymorphs, stereoisomers, prodrugs, solvates, and pharmaceutically acceptable salts. These compounds are particularly useful in treating various conditions mediated by adenosine A2A receptors, such as Parkinson's disease, Alzheimer's disease, neurodegenerative disorders, and more. The patent not only outlines the potential therapeutic uses but also discusses methods for the preparation of these compounds and related pharmaceutical compositions.
Career Highlights
Currently, Minakshi is employed at Advinus Therapeutics Private Limited, where she continues to push the boundaries of pharmaceutical research and development. Her expertise in chemistry and pharmacology has positioned her as a valuable asset in her organization, contributing to innovative solutions for health challenges.
Collaborations
Throughout her career, Minakshi has collaborated with other talented professionals, including coworkers Dinesh Barawkar and Sujay Basu. These collaborations enhance the research environment, fostering creativity and knowledge exchange that is essential for groundbreaking discoveries in the field.
Conclusion
Minakshi Naykodi's innovative work in the development of fused tricyclic compounds highlights the importance of research and invention in addressing complex health issues. Her contributions at Advinus Therapeutics Private Limited and her patent achievements demonstrate her commitment to improving human health through scientific advancement. The future looks bright for her continued work in the ever-evolving field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile